Close Menu

NEW YORK – At the beginning of March, lawmakers from the House and Senate introduced legislation to establish a framework for US Food and Drug Administration oversight of diagnostic testing.

Called the Verifying Accurate, Leading-edge IVCT Development (VALID) Act, the bill would resolve longstanding questions over FDA's authority to regulate laboratory-developed tests (LDTs), explicitly giving the agency the authority to review and approve these tests.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.